| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/20/2008 | CN101125162A Blood-tonifying medicine preparation and its preparation method |
| 02/20/2008 | CN101125161A Burn cream for treating burn and scald and its preparation method |
| 02/20/2008 | CN101125160A Method for preparing preparation for treating gastroenteritis and its new use |
| 02/20/2008 | CN101125152A 纳米级有机硒 Nanoscale organic selenium |
| 02/20/2008 | CN101125150A Application of nanometer zinc oxide in preparing medicine for treating malignant tumor |
| 02/20/2008 | CN101125147A Glucosamine calcium medicine preparation, preparation method and application thereof |
| 02/20/2008 | CN101125146A Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor |
| 02/20/2008 | CN101125145A Local using prostaglandin micro emulsion and its preparation method |
| 02/20/2008 | CN101125144A Compound medicine for treating diabetes |
| 02/20/2008 | CN101125143A Hypertension-treating compound medicine |
| 02/20/2008 | CN101125142A Application of artemisine in preparing artitumor multi-medicine-resistant medicine |
| 02/20/2008 | CN101125141A Anticancer medicine composition and its application in preparing anticancer medicine |
| 02/20/2008 | CN101125140A Application of dihydroartemisinin in reinforcing chemotherapy medicine antitumor curative effect |
| 02/20/2008 | CN101125139A Application of procyanidin B2 in preparing medicine for preventing and treating diabetes and vascular complication |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/20/2008 | CN101125137A Pharmaceutical salts |
| 02/20/2008 | CN101125136A Application of alpinia officinarum hance diarylheptanes compound in pain-alleviating and anti-inflammatory and its extracting method |
| 02/20/2008 | CN101125135A Artemether cataplasma and its application |
| 02/20/2008 | CN101125134A Hydrochloric tamsulosin sustained-release capsule and its preparation method |
| 02/20/2008 | CN101125133A Unsaturated fatty acid microcapsule preparing technology and application |
| 02/20/2008 | CN101125131A Method for preparing flupentixol and melitracen capsule |
| 02/20/2008 | CN101125129A Acemetacin sustained-release preparation and preparation method |
| 02/20/2008 | CN101125128A Sustained-release tablet composition of pramipexole |
| 02/20/2008 | CN101125127A Artemisinin derivatives freeze-dried preparation and preparation method |
| 02/20/2008 | CN101125125A Methylergometrine Maleate powder injection and preparation method thereof |
| 02/20/2008 | CN101125123A Red sage root A magnesium injection preparation and preparation method thereof |
| 02/20/2008 | CN100369936C Sulfonated changium root polysaccharides and preparing method and use thereof |
| 02/20/2008 | CN100369926C Nucleotide lipid ester derivatives |
| 02/20/2008 | CN100369925C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369916C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369915C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369914C 3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine |
| 02/20/2008 | CN100369913C Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 02/20/2008 | CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 02/20/2008 | CN100369908C New taxane derivatives |
| 02/20/2008 | CN100369906C Method for producing 3-amidinophenylalanine derivatives |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369903C Five-membered-ring compound |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369896C Cyclic amino compounds |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369887C Inhibitors of oleamide hydrolase |
| 02/20/2008 | CN100369625C Externally applied medicinal ointment for treating scald and burn |
| 02/20/2008 | CN100369620C Chinese medicine for antioxidation and antisenility and its prepn. |
| 02/20/2008 | CN100369612C External-use powder medicine for wetting burn and empyrosis and its preparing method |
| 02/20/2008 | CN100369610C Plant extract for preventing and treating diabetes, and preparing method and pharmaceutic use thereof |
| 02/20/2008 | CN100369609C Compound dired Chinese forest frog oil capsule and its preparation |
| 02/20/2008 | CN100369608C Suspension spray for treating allergic rhinitis and its preparing method |
| 02/20/2008 | CN100369607C Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method |
| 02/20/2008 | CN100369606C Inclusion containing raltitrexed and preparation |
| 02/20/2008 | CN100369605C Blood lipid ameliopant composition |
| 02/20/2008 | CN100369604C Drop pill type eye drip fluid of chloramphenicol, and preparation method |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | USRE40086 [4S-(4,12a alpha )]-4-(dimethylamino)-7-(substituted)-9-(substituted amino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12 a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamides; wide spectrum bactericides, including tetracycline-resistant strains; veterinary medicine |
| 02/19/2008 | US7333894 Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332629 Amide derivatives of the compound anacardic acid from Cashew Nut Shell Oil; to treat cancer, AIDS, HIV infection, and asthma |
| 02/19/2008 | US7332615 Bioavailability; acid, amine, or polyhydroxy-functionalized; e.g. mono-[1-(4,8-dioxo-4,8-dihydrobenzo[1,2-b;5,4-b']dithiophen-2-yl)-methyl]succinate; antitumor agents; non-small cell lung cancer, breast cancer, nasopharynx carcinoma and prostate cancer |
| 02/19/2008 | US7332614 Process for cross coupling indoles |
| 02/19/2008 | US7332612 Amorphous and crystalline forms of losartan potassium and process for their preparation |
| 02/19/2008 | US7332610 Chemical intermediates for production of sibutramine |
| 02/19/2008 | US7332608 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 02/19/2008 | US7332607 Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 02/19/2008 | US7332605 reacting substituted 5,6,7,8-tetrahydroquinolinylamine bearing a phthalimide protecting group or a di-tert-butoxycarbonyl protecting group with an alkyl aldehyde to produce an imine; reduction with metal hydride; reacting the secondary amine with a 2-halomethylbenzimidazole; hydrolysis deprotecting |
| 02/19/2008 | US7332599 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332572 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 02/19/2008 | US7332527 Cross-linked ionic core micelles |
| 02/19/2008 | US7332526 Side effect reduction; latanoprost; it is believed that TFF-peptides may be present during healing and other related processes in the eye |
| 02/19/2008 | US7332525 Antiandrogens and estrogen receptor moderator; synergistic mixture; side effect reduction |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332523 TNP-470 polymer conjugates and use thereof |
| 02/19/2008 | US7332522 Liver function protecting or ameliorating agent |
| 02/19/2008 | US7332521 Substituted indoles |
| 02/19/2008 | US7332520 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/19/2008 | US7332519 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
| 02/19/2008 | US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding |
| 02/19/2008 | US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 02/19/2008 | US7332515 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332513 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 02/19/2008 | US7332512 Halogenated nitrobutadienes for controlling animal pests |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332510 Metabotropic glutamate (mGluR5) receptor mediated disorders; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain; containing pyridin-4-ylethynyl functionality |
| 02/19/2008 | US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths |
| 02/19/2008 | US7332508 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332506 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 02/19/2008 | US7332505 Gastrointestinal disorders; facilitating healing and decreasing recurrence of ulcers; low dosage, reduced side effects |
| 02/19/2008 | US7332504 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/19/2008 | US7332503 Aporphine esters and their use in therapy |
| 02/19/2008 | US7332502 Phenanthroindolizidine alkaloids |
| 02/19/2008 | US7332501 Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists |
| 02/19/2008 | US7332500 Heterocyclic antiviral compounds |